Active Pharmaceutical Ingredients
Active Pharmaceutical Ingredients News
Stressing that while framing any policy, there is a need to look at it from India's strategic point of view, Modi said there were instances when notes from the national security council were not given due importance
The Indian pharma industry is strongly positioned in terms of production capacity and is also committed to growth
Coronavirus outbreak highlighted vulnerabilities in medical manufacturing supply chain: Fitch Solutions
With pharmaceutical supply chains under immense pressure due to COVID-19, China's role as a global ingredient producer has come under scrutiny, Fitch Solutions has said
Pharma major Lupin on Wednesday said it has received an establishment inspection report (EIR) from the US health regulator for its Mandideep Unit II facility in Madhya Pradesh
Coronavirus outbreak: Govt restrains exports of a few APIs, formulations; lists essential medicines that could run out of stock
In a notification, the government put curbs on the exports of certain APIs and formulations, including Paracetamol, Vitamin B1 and B12 amid the coronavirus outbreak claimed over 3,000 lives across the world.
Coronavirus outbreak: ICRA revises domestic pharma industry outlook to negative amid lockouts in parts of China
The domestic pharma industry is highly dependent on imports, with more than 60 percent of its active pharmaceutical ingredients (API) requirement being shipped from overseas locations, especially China.
India-Pakistan air strikes: Drug exporters wary of tension between two countries, apprehensive about future
The Indian pharmaceutical companies exports over $140 million to Pakistan with 50 percent active pharmaceutical ingredients.
The Indian government has issued show cause notices to, and may soon blacklist, eight Chinese pharmaceutical companies found to be supplying poor quality raw material to drug manufacturers in this country
The country's second-largest drug maker last week said it received a warning letter from the US drug regulator relating to two of its API manufacturing plants and a formulation plant located in Andhra Pradesh and Telangana.